BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boyapati RK, Rossi AG, Satsangi J, Ho GT. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol. 2016;9:567-582. [PMID: 26931062 DOI: 10.1038/mi.2016.14] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Hultström M, Becirovic-Agic M, Jönsson S. Comparison of acute kidney injury of different etiology reveals in-common mechanisms of tissue damage. Physiol Genomics 2018;50:127-41. [PMID: 29341864 DOI: 10.1152/physiolgenomics.00037.2017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
2 Deng X, Yang G, Zheng X, Yang Y, Qin H, Liu ZX, Deng H, Liu SM. Plasma mtDNA copy numbers are associated with GSTK1 expression and inflammation in type 2 diabetes. Diabet Med 2020;37:1874-8. [PMID: 31502701 DOI: 10.1111/dme.14132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhao F, Zheng T, Gong W, Wu J, Xie H, Li W, Zhang R, Liu P, Liu J, Wu X, Zhao Y, Ren J. Extracellular vesicles package dsDNA to aggravate Crohn's disease by activating the STING pathway. Cell Death Dis 2021;12:815. [PMID: 34453041 DOI: 10.1038/s41419-021-04101-z] [Reference Citation Analysis]
4 Dunsmore G, Koleva P, Ghobakhloo N, Sutton R, Ambrosio L, Meng X, Hotte N, Nguyen V, Madsen KL, Dieleman LA, Huang V, Elahi S. Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy. J Crohns Colitis 2019;13:230-44. [PMID: 30272151 DOI: 10.1093/ecco-jcc/jjy147] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
5 Ke P, Shao BZ, Xu ZQ, Chen XW, Liu C. Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease. Front Immunol 2016;7:695. [PMID: 28119697 DOI: 10.3389/fimmu.2016.00695] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
6 Jun YK, Kwon SH, Yoon HT, Park H, Soh H, Lee HJ, Im JP, Kim JS, Kim JW, Koh SJ. Toll-like receptor 4 regulates intestinal fibrosis via cytokine expression and epithelial-mesenchymal transition. Sci Rep 2020;10:19867. [PMID: 33199767 DOI: 10.1038/s41598-020-76880-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Chaudhry SR, Hafez A, Rezai Jahromi B, Kinfe TM, Lamprecht A, Niemelä M, Muhammad S. Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH). Int J Mol Sci 2018;19:E2035. [PMID: 30011792 DOI: 10.3390/ijms19072035] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
8 Li H, Fan C, Feng C, Wu Y, Lu H, He P, Yang X, Zhu F, Qi Q, Gao Y, Zuo J, Tang W. Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity. Br J Pharmacol 2019;176:2209-26. [PMID: 30883697 DOI: 10.1111/bph.14667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
9 Joeris T, Müller-Luda K, Agace WW, Mowat AM. Diversity and functions of intestinal mononuclear phagocytes. Mucosal Immunol 2017;10:845-64. [PMID: 28378807 DOI: 10.1038/mi.2017.22] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 18.8] [Reference Citation Analysis]
10 Kvivik I, Grimstad T, Jonsson G, Kvaløy JT, Omdal R. Anti-HMGB1 auto-Abs influence fatigue in patients with Crohn's disease. Innate Immun 2021;27:286-93. [PMID: 33940970 DOI: 10.1177/17534259211014252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Valatas V, Filidou E, Drygiannakis I, Kolios G. Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface. Ann Gastroenterol 2017;30:393-404. [PMID: 28655975 DOI: 10.20524/aog.2017.0146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
12 Ho GT, Cartwright JA, Thompson EJ, Bain CC, Rossi AG. Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing. Inflamm Bowel Dis 2020;26:1131-43. [PMID: 32232386 DOI: 10.1093/ibd/izaa045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
13 Krawiec P, Pac-Kożuchowska E. Cathelicidin - A Novel Potential Marker of Pediatric Inflammatory Bowel Disease. J Inflamm Res 2021;14:163-74. [PMID: 33519224 DOI: 10.2147/JIR.S288742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fujita Y, Khateb A, Li Y, Tinoco R, Zhang T, Bar-Yoseph H, Tam MA, Chowers Y, Sabo E, Gerassy-Vainberg S, Starosvetsky E, James B, Brown K, Shen-Orr SS, Bradley LM, Tessier PA, Ronai ZA. Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis. Cell Rep 2018;24:3296-3311.e6. [PMID: 30232010 DOI: 10.1016/j.celrep.2018.08.057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
15 Li H, Zhang Y, Liu M, Fan C, Feng C, Lu Q, Xiang C, Lu H, Yang X, Wu B, Zou D, Tang W. Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis. Acta Pharmaceutica Sinica B 2022;12:228-45. [DOI: 10.1016/j.apsb.2021.04.007] [Reference Citation Analysis]
16 Chen C, Lin Z, Zhang X, Zhang X, Cheng Z, Jin T, Liu T, Deng L, Guo J, Wang G, Xia Q. Extracellular histones cause intestinal epithelium injury and disrupt its barrier function in vitro and in vivo. Toxicology 2022;:153117. [PMID: 35122914 DOI: 10.1016/j.tox.2022.153117] [Reference Citation Analysis]
17 Geng F, Liu J, Yin C, Zhang S, Pan Y, Sun H. Porphyromonas gingivalis lipopolysaccharide induced RIPK3/MLKL-mediated necroptosis of oral epithelial cells and the further regulation in macrophage activation. Journal of Oral Microbiology 2022;14:2041790. [DOI: 10.1080/20002297.2022.2041790] [Reference Citation Analysis]
18 Harrington JS, Choi AMK, Nakahira K. Mitochondrial DNA in Sepsis. Curr Opin Crit Care 2017;23:284-90. [PMID: 28562385 DOI: 10.1097/MCC.0000000000000427] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 8.8] [Reference Citation Analysis]
19 Gong W, Zheng T, Guo K, Fang M, Xie H, Li W, Tang Q, Hong Z, Ren H, Gu G, Wang G, Wu X, Zhao Y, Ren J. Mincle/Syk Signalling Promotes Intestinal Mucosal Inflammation Through Induction of Macrophage Pyroptosis in Crohn’s Disease. Journal of Crohn's and Colitis 2020;14:1734-47. [DOI: 10.1093/ecco-jcc/jjaa088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
20 Burcham LR, Le Breton Y, Radin JN, Spencer BL, Deng L, Hiron A, Ransom MR, Mendonça JDC, Belew AT, El-Sayed NM, McIver KS, Kehl-Fie TE, Doran KS. Identification of Zinc-Dependent Mechanisms Used by Group B Streptococcus To Overcome Calprotectin-Mediated Stress. mBio 2020;11:e02302-20. [PMID: 33173000 DOI: 10.1128/mBio.02302-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Wu T, Gagnon A, Mcgourty K, Dossantos R, Chanetsa L, Zhang B, Bello D, Kelleher SL. Zinc Exposure Promotes Commensal-to-Pathogen Transition in Pseudomonas aeruginosa Leading to Mucosal Inflammation and Illness in Mice. IJMS 2021;22:13321. [DOI: 10.3390/ijms222413321] [Reference Citation Analysis]
22 van der Gracht E, Zahner S, Kronenberg M. When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD. Mediators Inflamm 2016;2016:9765238. [PMID: 27578924 DOI: 10.1155/2016/9765238] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
23 Tan G, Huang C, Chen J, Zhi F. HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway. J Hematol Oncol 2020;13:149. [PMID: 33160389 DOI: 10.1186/s13045-020-00985-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
24 Meriwether D, Sulaiman D, Volpe C, Dorfman A, Grijalva V, Dorreh N, Solorzano-Vargas RS, Wang J, O'Connor E, Papesh J, Larauche M, Trost H, Palgunachari MN, Anantharamaiah GM, Herschman HR, Martin MG, Fogelman AM, Reddy ST. Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model. J Clin Invest 2019;129:3670-85. [PMID: 31184596 DOI: 10.1172/JCI123700] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
25 Davila J, Levin S, Radi Z. Cell Injury and Necrosis. Comprehensive Toxicology. Elsevier; 2018. pp. 404-53. [DOI: 10.1016/b978-0-12-801238-3.64220-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Tu L, Chen J, Xu D, Xie Z, Yu B, Tao Y, Shi G, Duan L. IL-33-induced alternatively activated macrophage attenuates the development of TNBS-induced colitis. Oncotarget 2017;8:27704-14. [PMID: 28423665 DOI: 10.18632/oncotarget.15984] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
27 Palone F, Vitali R, Cucchiara S, Mennini M, Armuzzi A, Pugliese D, DʼIncà R, Barberio B, Stronati L. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission. Inflamm Bowel Dis 2016;22:2886-93. [PMID: 27755215 DOI: 10.1097/MIB.0000000000000938] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
28 Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in Inflammation. Front Immunol 2018;9:1298. [PMID: 29942307 DOI: 10.3389/fimmu.2018.01298] [Cited by in Crossref: 252] [Cited by in F6Publishing: 250] [Article Influence: 63.0] [Reference Citation Analysis]
29 Arafah K, Kriegsmann M, Renner M, Lasitschka F, Fresnais M, Kriegsmann K, von Winterfeld M, Goeppert B, Kriegsmann J, Casadonte R, Kazdal D, Bulet P, Longuespée R. Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease. Proteomics Clin Appl 2020;14:e1900110. [PMID: 32003543 DOI: 10.1002/prca.201900110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Brajer-Luftmann B, Nowicka A, Kaczmarek M, Wyrzykiewicz M, Yasar S, Piorunek T, Sikora J, Batura-Gabryel H. Damage-Associated Molecular Patterns and Myeloid-Derived Suppressor Cells in Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease Patients. J Immunol Res 2019;2019:9708769. [PMID: 31355298 DOI: 10.1155/2019/9708769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Gong W, Guo K, Zheng T, Fang M, Xie H, Li W, Hong Z, Ren H, Gu G, Wang G, Wang Z, Wu X, Ren J. Preliminary exploration of the potential of spliceosome‐associated protein 130 for predicting disease severity in Crohn's disease. Ann N Y Acad Sci 2019;1462:128-38. [DOI: 10.1111/nyas.14240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Gonzalez Acera M, Bubeck M, Mascia F, Diemand L, Sturm G, Kühl AA, Atreya R, Lie DC, Neurath MF, Schumann M, Klose CSN, Trajanoski Z, Becker C, Patankar JV. Dynamic, Transient, and Robust Increase in the Innervation of the Inflamed Mucosa in Inflammatory Bowel Diseases. Cells 2021;10:2253. [PMID: 34571902 DOI: 10.3390/cells10092253] [Reference Citation Analysis]
33 Friedrich M, Pohin M, Jackson MA, Korsunsky I, Bullers SJ, Rue-Albrecht K, Christoforidou Z, Sathananthan D, Thomas T, Ravindran R, Tandon R, Peres RS, Sharpe H, Wei K, Watts GFM, Mann EH, Geremia A, Attar M, McCuaig S, Thomas L, Collantes E, Uhlig HH, Sansom SN, Easton A, Raychaudhuri S, Travis SP, Powrie FM; Oxford IBD Cohort Investigators., Roche Fibroblast Network Consortium. IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. Nat Med 2021;27:1970-81. [PMID: 34675383 DOI: 10.1038/s41591-021-01520-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological Mechanisms Underpinning Faecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Clin Exp Immunol. 2019;199:24-38. [PMID: 31777058 DOI: 10.1111/cei.13397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
35 Hooper KM, Barlow PG, Henderson P, Stevens C. Interactions Between Autophagy and the Unfolded Protein Response: Implications for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019;25:661-671. [PMID: 30590697 DOI: 10.1093/ibd/izy380] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
36 Kontny E, Dmowska-Chalaba J. Spondyloarthritis patients with and without intestinal symptoms - searching for discriminating biomarkers. Cent Eur J Immunol 2019;44:414-22. [PMID: 32140054 DOI: 10.5114/ceji.2019.92802] [Reference Citation Analysis]
37 Kushkevych I, Martínková K, Vítězová M, Rittmann SKR. Intestinal Microbiota and Perspectives of the Use of Meta-Analysis for Comparison of Ulcerative Colitis Studies. J Clin Med 2021;10:462. [PMID: 33530381 DOI: 10.3390/jcm10030462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Caër C, Gorreja F, Forsskåhl SK, Brynjolfsson SF, Szeponik L, Magnusson MK, Börjesson LG, Block M, Bexe-Lindskog E, Wick MJ. TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease Patients. J Crohns Colitis 2021;15:1346-61. [PMID: 33537747 DOI: 10.1093/ecco-jcc/jjab022] [Reference Citation Analysis]
39 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Cheng Y, Hall TR, Xu X, Yung I, Souza D, Zheng J, Schiele F, Hoffmann M, Mbow ML, Garnett JP, Li J. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease. EBioMedicine 2021;75:103758. [PMID: 34933179 DOI: 10.1016/j.ebiom.2021.103758] [Reference Citation Analysis]
41 Boyapati RK, Kalla R, Satsangi J, Ho GT. Biomarkers in Search of Precision Medicine in IBD. Am J Gastroenterol. 2016;111:1682-1690. [PMID: 27670602 DOI: 10.1038/ajg.2016.441] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
42 Burgueño JF, Abreu MT. Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol 2020;17:263-78. [DOI: 10.1038/s41575-019-0261-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 26.5] [Reference Citation Analysis]
43 Mizoguchi E, Subramaniam R, Okada T, Mizoguchi A. A Review of Selected IBD Biomarkers: From Animal Models to Bedside. Diagnostics (Basel) 2021;11:207. [PMID: 33573291 DOI: 10.3390/diagnostics11020207] [Reference Citation Analysis]
44 Paudel YN, Angelopoulou E, Piperi C, Balasubramaniam VR, Othman I, Shaikh MF. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. European Journal of Pharmacology 2019;858:172487. [DOI: 10.1016/j.ejphar.2019.172487] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 16.3] [Reference Citation Analysis]
45 Yang Y, Yang J, Yu B, Li L, Luo L, Wu F, Wu B. Association between circulating mononuclear cell mitochondrial DNA copy number and in-hospital mortality in septic patients: A prospective observational study based on the Sepsis-3 definition. PLoS One 2019;14:e0212808. [PMID: 30794688 DOI: 10.1371/journal.pone.0212808] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
46 Huang K, Dong W, Liu W, Yan Y, Wan P, Peng Y, Xu Y, Zeng X, Cao Y. 2-O-β-d-Glucopyranosyl-l-ascorbic Acid, an Ascorbic Acid Derivative Isolated from the Fruits of Lycium Barbarum L., Modulates Gut Microbiota and Palliates Colitis in Dextran Sodium Sulfate-Induced Colitis in Mice. J Agric Food Chem 2019;67:11408-19. [PMID: 31556290 DOI: 10.1021/acs.jafc.9b04411] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
47 Qi M, Tan B, Wang J, Liao S, Deng Y, Ji P, Song T, Zha A, Yin Y. The microbiota-gut-brain axis: A novel nutritional therapeutic target for growth retardation. Crit Rev Food Sci Nutr 2021;:1-26. [PMID: 33523720 DOI: 10.1080/10408398.2021.1879004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chaudhry SR, Lehecka M, Niemelä M, Muhammad S. Sterile Inflammation, Potential Target in Aneurysmal Subarachnoid Hemorrhage. World Neurosurg 2019;123:159-60. [PMID: 30580066 DOI: 10.1016/j.wneu.2018.12.061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
49 Schoultz I, Keita ÅV. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Cells 2019;8:E193. [PMID: 30813280 DOI: 10.3390/cells8020193] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 17.0] [Reference Citation Analysis]
50 Lin TL, Lu CC, Lai WF, Wu TS, Lu JJ, Chen YM, Tzeng CM, Liu HT, Wei H, Lai HC. Role of gut microbiota in identification of novel TCM-derived active metabolites. Protein Cell 2021;12:394-410. [PMID: 32929698 DOI: 10.1007/s13238-020-00784-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Shi Y, He C, Ma C, Yu T, Cong Y, Cai W, Liu Z. Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function. Mucosal Immunol 2018;11:835-45. [DOI: 10.1038/mi.2017.95] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
52 Heil M, Vega-Muñoz I. Nucleic Acid Sensing in Mammals and Plants: Facts and Caveats. Int Rev Cell Mol Biol 2019;345:225-85. [PMID: 30904194 DOI: 10.1016/bs.ircmb.2018.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
53 Ali Z, Waseem S, Shahzadi I, Bukhari S, Anis RA, Ahmed I, Anees M. Association of cell free mitochondrial DNA and caspase-1 expression with disease severity and ARTs efficacy in HIV infection. Mol Biol Rep 2021;48:3327-36. [PMID: 33886057 DOI: 10.1007/s11033-021-06313-0] [Reference Citation Analysis]
54 Boyapati RK, Dorward DA, Tamborska A, Kalla R, Ventham NT, Doherty MK, Whitfield PD, Gray M, Loane J, Rossi AG. Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD. Inflamm Bowel Dis. 2018;24:2113-2122. [PMID: 29718255 DOI: 10.1093/ibd/izy095] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
55 Dos Santos Ramos A, Viana GCS, de Macedo Brigido M, Almeida JF. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets. Pharmacol Res 2021;171:105779. [PMID: 34298111 DOI: 10.1016/j.phrs.2021.105779] [Reference Citation Analysis]
56 Schoultz I, Keita ÅV. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells 2020;9:E1909. [PMID: 32824536 DOI: 10.3390/cells9081909] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
57 Wyczanska M, Lange-Sperandio B. DAMPs in Unilateral Ureteral Obstruction. Front Immunol 2020;11:581300. [PMID: 33117389 DOI: 10.3389/fimmu.2020.581300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
58 Kubiritova Z, Radvanszky J, Gardlik R. Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E3662. [PMID: 31357438 DOI: 10.3390/ijms20153662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
59 Tan IL, Barisani D, Panceri R, Modderman R, Visschedijk M, Weersma RK, Wijmenga C, Jonkers I, Coutinho de Almeida R, Withoff S. A Combined mRNA- and miRNA-Sequencing Approach Reveals miRNAs as Potential Regulators of the Small Intestinal Transcriptome in Celiac Disease. Int J Mol Sci 2021;22:11382. [PMID: 34768815 DOI: 10.3390/ijms222111382] [Reference Citation Analysis]
60 Boyapati RK, Tamborska A, Dorward DA, Ho GT. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res 2017;6:169. [PMID: 28299196 DOI: 10.12688/f1000research.10397.1] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 16.8] [Reference Citation Analysis]
61 Wu R, Zhang Y, Xiang Y, Tang Y, Cui F, Cao J, Zhou L, You Y, Duan L. Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B. J Transl Med 2018;16:83. [PMID: 29615081 DOI: 10.1186/s12967-018-1462-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
62 Zhu Z, Liu Y, Wu D, Wang H. Association Between Mitochondrial DNA Copy Number and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Dose-Response Meta-Analysis. Med Sci Monit 2021;27:e928327. [PMID: 33468984 DOI: 10.12659/MSM.928327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Crittenden S, Cheyne A, Adams A, Forster T, Robb CT, Felton J, Ho GT, Ruckerl D, Rossi AG, Anderton SM, Ghazal P, Satsangi J, Howie SE, Yao C. Purine metabolism controls innate lymphoid cell function and protects against intestinal injury. Immunol Cell Biol 2018;96:1049-59. [PMID: 29758102 DOI: 10.1111/imcb.12167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
64 Nanini HF, Bernardazzi C, Castro F, de Souza HSP. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets. World J Gastroenterol 2018; 24(41): 4622-4634 [PMID: 30416310 DOI: 10.3748/wjg.v24.i41.4622] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
65 Ali Z, Waseem S, Anis RA, Anees M. Assessment of cell free mitochondrial DNA as a biomarker of disease severity in different viral infections. Pak J Med Sci 2020;36:860-6. [PMID: 32704253 DOI: 10.12669/pjms.36.5.2476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Tan G, Huang C, Chen J, Chen B, Zhi F. Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn's disease by promoting intestinal inflammation. Cell Rep 2021;35:109265. [PMID: 34133932 DOI: 10.1016/j.celrep.2021.109265] [Cited by in F6Publishing: 1] [Reference Citation Analysis]